By Susan Scutti | Mon, 12/09/2013 - 17:59
Scientists convert common plastic materials like PET into non-toxic materials designed to specifically target and attack fungal infections, including athlete's foot and yeast infections.
By Anthony Rivas | Mon, 12/09/2013 - 17:02
Hoping to halt the meningitis B outbreak that has caused eight people to fall ill, Princeton University began administering the vaccine Bexsero, which is not yet approved in the U.S.
By Chris Weller | Mon, 12/09/2013 - 16:57
Due to the brain's short-term withdrawal from alcohol, driving while hungover shows the same symptoms of driving while drunk.
By Peter Sergo | Mon, 12/09/2013 - 15:44
A study found that neither the financial crisis nor the Affordable Care Act are behind the decade-long decline in the growth rate of health care costs.
By Chris Weller | Mon, 12/09/2013 - 14:28
Scientists have developed a contact lens that delivers a continuous dose of glaucoma medication, making eye drops unnecessary.
By Susan Scutti | Mon, 12/09/2013 - 13:10
Some experimental genetic therapies — precision medicines — are proving to be both effective and safe for the treatment of blood disorder patients.
By Justin Caba | Sat, 12/07/2013 - 16:47
A recent study led by the Cleveland Clinic found the two of the most common drugs used to treat type-2 diabetes also lowers women's risk of developing cancer.
By Susan Scutti | Fri, 12/06/2013 - 18:31
The FDA approved Auxilium Pharmaceuticals Inc.’s Xiaflex for the treatment of Peyronie’s disease, a painful curvature of the penis.
By Justin Caba | Fri, 12/06/2013 - 11:00
Researchers in Germany are in the middle of ongoing clinical trials to test a possible cancer-fighting remedy derived from a compound found in curry.
By Lizette Borreli | Thu, 12/05/2013 - 17:37
Testosterone and flibanserin treatments may increase womens’ sex drive.
By Susan Scutti | Thu, 12/05/2013 - 12:15
Yesterday, Pfizer Inc. updated its clinical trial data access policy and will soon begin to share data and results with study participants and researchers.
By Justin Caba | Thu, 12/05/2013 - 11:01
Solanezumab, a new Alzheimer's drug in the middle of clinical trials, could lead to a significant breakthrough in dementia research within five years.
By Lizette Borreli | Wed, 12/04/2013 - 18:17
Drug-free water-based gel treatment, Flexiseq, is found to alleviate joint pain and improve mobility in arthritis patients with no side-effects.